A Patient Navigator may assist during your patient's treatment with coverage, reimbursement and financial assistance support.
To contact a WILSERDLY Patient Navigator Call (888) 249-4918
If eligible commercially insured patients need assistance with their drug out-of-pocket costs, the Genentech Co-pay Program for WILSERDLY may help.
To get started, call 888-249-4918 or visit Genentechcopay.com.
Eligibility criteria and benefit limits apply. Not valid for patients whose prescriptions are reimbursed under any federal or state government programs to pay for their Genentech medicine. Patients must be taking the Genentech medicine for an FDA-approved indication. Please visit the Co-pay Program website for the full list of Terms and Conditions.
For eligible patients with commercial or public health insurance, WILSERDLY Access Solutions offers referrals to independent co-pay assistance foundations that may be able to help.
Independent co-pay assistance foundations have their own rules for eligibility. Genentech has no involvement or influence in independent foundation decision-making or eligibility criteria and does not know if a foundation will be able to help your patient. We can only refer your patient to a foundation that supports their disease state. This information is provided as a resource for you. Genentech does not endorse or show preference for any particular foundation. The foundations in this list may not be the only ones that might be able to help your patient.
If patients don’t have health insurance coverage or have financial concerns and meet eligibility criteria, they may be able to get Genentech medicine at no cost from the Genentech Patient Foundation.
Call (888) 941-3331 to speak with a live Foundation Specialist. We offer support in many different languages.
To be eligible for free Genentech medicine from the Genentech Patient Foundation, insured patients who have coverage for their medicine should try to pursue other forms of financial assistance, if available, and meet certain income requirements. Uninsured patients and insured patients without coverage for their medicine must meet a different set of income requirements. Genentech reserves the right to modify or discontinue the program at any time and to verify the accuracy of information submitted.
This coding information may assist you as you complete the payer forms for WILSERDLY. These resources are provided for informational purposes only. Please visit CMS.gov or other payers’ websites to obtain additional guidance on their processes related to billing and coding for single-use vials and wastage.
Correct coding is the responsibility of the provider submitting the claim for the item or service. Please check with the payer to verify codes and special billing requirements. Genentech does not make any representation or guarantee concerning reimbursement or coverage for any item or service.
If your patient’s health insurance plan has issued a denial, your Field Reimbursement Manager (FRM) or WILSERDLY Access Solutions Specialist can provide resources as you prepare an appeal submission, as per your patient’s plan requirements.
If a plan issues a denial:
The denial should be reviewed, along with the health insurance plan’s guidelines, to determine what to include in your patient’s appeal submission
Your FRM or WILSERDLY Access Solutions Specialist has local payer coverage expertise and can help you determine specific requirements for your patient
A sample letter of medical necessity and appeal letter for WILSERDLY are included below. Additional tips and considerations are available in Resources.
Sample Letter of Appeal for WILSERDLY
Sample Letter of Medical Necessity for WILSERDLY
Appeals cannot be completed or submitted by WILSERDLY Access Solutions on your behalf.
WILSERDLY Access Solutions can conduct a benefits investigation (BI) to help you determine if WILSERDLY is covered, if prior authorizations (PAs) are required, which specialty pharmacy (SP) the health insurance plan prefers and if financial assistance might be needed.
Potential outcomes of a BI:
Both the WILSERDLY Start Form and the Patient Consent Form must be received before WILSERDLY Access Solutions can begin helping your patient.
Forms can be downloaded from Enrollment or submitted online via My Patient Solutions®.
A sample letter of medical necessity and appeal letter for WILSERDLY are included below. Additional tips and considerations are available in Resources.
Sample Letter of Appeal for WILSERDLY
Sample Letter of Medical Necessity for WILSERDLY
The completion and submission of coverage- or reimbursement-related documentation are the responsibility of the patient and health care provider. Genentech makes no representation or guarantee concerning coverage or reimbursement for any service or item.
WILSERDLY Access Solutions can help you identify if a prior authorization (PA) is necessary and offer resources as you request it for your patient. Both the WILSERDLY Start Form and the Patient Consent Form must be received before WILSERDLY Access Solutions can begin helping your patient.
Forms can be downloaded from Enrollment or submitted online via My Patient Solutions®.
If your patient’s request for a PA is not granted, your Field Reimbursement Manager (FRM) or WILSERDLY Access Solutions Specialist can work with you to determine your next steps. You can find more tips like this in Resources.
A sample letter of medical necessity and appeal letter for WILSERDLY are included below. Additional tips and considerations are available in Resources.
Sample Letter of Appeal for WILSERDLY
Sample Letter of Medical Necessity for WILSERDLY
The completion and submission of coverage- or reimbursement-related documentation are the responsibility of the patient and health care provider. Genentech makes no representation or guarantee concerning coverage or reimbursement for any service or item.
With the WILSERDLY Bridge Program, eligible patients taking WILSERDLY may receive free medicine while awaiting an insurance coverage determination.
If you think your patient qualifies for the WILSERDLY Bridge Program, submit the completed WILSERDLY Start Form, including the completed Patient Consent Form and Bridge Program section on page 5, to WILSERDLY Access Solutions.
Forms can be downloaded from Enrollment or submitted online via My Patient Solutions®.
For more information, please contact your WILSERDLY representative. You can also call WILSERDLY Access Solutions at (888) 249-4918 to learn more.
Subject to eligibility requirements and terms and conditions. This program is void where prohibited by law and may not be used in or by residents of restricted states, if applicable.
To enroll in Genentech patient support services, both you and your patient will need to complete the required forms.
Enroll patients online and manage service requests using My Patient Solutions®
Both forms must be received before Genentech can begin helping your patient. Only the information requested on these forms is required. Providing unrequested documents or information will delay processing.
WILSERDLY Access Solutions works with specialty pharmacies (SPs) to help patients receive their medicines.
An SP may provide the following services:
You can work with your preferred SP or contact WILSERDLY Access Solutions to learn which SP the patient’s health insurance plan requires.
| Distributor | Telephone | Fax | Web Orders |
|---|---|---|---|
| ASD Healthcare (Cencora) | 800-746-6273 | 800-547-9413 | www.asdhealthcare.com |
| Besse Medical (Cencora) | 800-543-2111 | 800-543-8695 | www.besse.com/home |
| Cardinal Health Specialty Pharmaceutical Distribution | 866-677-4844 | N/A | www.cardinalhealth.com/en/solutions/specialty-distribution.html |
| DMS Pharmaceutical | 877-788-1100 | 847-518-1105 | www.dmspharma.com/contact-us |
| McKesson Plasma and Biologics (MPB) | 877-625-2566 | N/A | www.mckesson.com/Pharmaceutical-Distribution/Plasma-Biologics/ |
| Morris & Dickson Specialty Distribution (MDSD) | 318-798-5295 | 318-798-5237 | www.mdspecialtydist.com |
| Morris & Dickson Pharmaceutical Distributor | 318-798-5295 | 318-798-5237 | www.morrisdickson.com/ |
| Oncology Supply (Cencora) | 800-633-7555 | 800-248-8205 | www.oncologysupply.com/ |
| Distributor | Telephone | Fax | Web Orders |
|---|---|---|---|
| ASD Healthcare (Cencora) | 800-746-6273 | 800-547-9413 | www.asdhealthcare.com |
| Besse Medical (Cencora) | 800-543-2111 | 800-543-8695 | www.besse.com/home |
| BioCareSD | 800-304-3064 | N/A | biocare-us.com |
| Cardinal Health Specialty Pharmaceutical Distribution | 866-677-4844 | N/A | www.cardinalhealth.com/en/solutions/specialty-distribution.html |
| CuraScript SD (Priority Health) | 877-599-7748 | 800-862-6208 | curascriptsd.com/Contact-Us |
| McKesson Plasma and Biologics (MPB) | 877-625-2566 | N/A | www.mckesson.com/Pharmaceutical-Distribution/Plasma-Biologics/ |
| Morris & Dickson Specialty Distribution (MDSD) | 318-798-5295 | 318-798-5237 | www.mdspecialtydist.com |
| Morris & Dickson Pharmaceutical Distributor | 318-798-5295 | 318-798-5237 | www.morrisdickson.com/ |
| Oncology Supply (Cencora) | 800-633-7555 | 800-248-8205 | www.oncologysupply.com/ |
| Distributor | Telephone | Fax | Web Orders |
|---|---|---|---|
| ASD Healthcare (Cencora) | 800-746-6273 | 800-547-9413 | www.asdhealthcare.com |
| Besse Medical (Cencora) | 800-543-2111 | 800-543-8695 | www.besse.com/home |
| BioCareSD | 800-304-3064 | N/A | biocare-us.com |
| Cardinal Health Specialty Pharmaceutical Distribution | 866-677-4844 | N/A | www.cardinalhealth.com/en/solutions/specialty-distribution.html |
| CuraScript SD (Priority Health) | 877-599-7748 | 800-862-6208 | curascriptsd.com/Contact-Us |
| McKesson Specialty Health (McKesson Specialty Care Distribution Corporation) | 800-482-6700 | N/A | www.mckesson.com/specialty/ |
| Morris & Dickson Specialty Distribution (MDSD) | 318-798-5295 | 318-798-5237 | www.mdspecialtydist.com |
| Morris & Dickson Pharmaceutical Distributor | 318-798-5295 | 318-798-5237 | www.morrisdickson.com/ |
| Oncology Supply (Cencora) | 800-633-7555 | 800-248-8205 | www.oncologysupply.com/ |
| Distributor | Telephone | Fax | Web Orders |
|---|---|---|---|
| ASD Healthcare (Cencora) | 800-746-6273 | 800-547-9413 | www.asdhealthcare.com |
| Besse Medical (Cencora) | 800-543-2111 | 800-543-8695 | www.besse.com/home |
| BioCareSD | 800-304-3064 | N/A | biocare-us.com |
| Cardinal Health Specialty Pharmaceutical Distribution | 866-677-4844 | N/A | www.cardinalhealth.com/en/solutions/specialty-distribution.html |
| CuraScript SD (Priority Health) | 877-599-7748 | 800-862-6208 | curascriptsd.com/Contact-Us |
| McKesson Plasma and Biologics (MPB) | 877-625-2566 | N/A | www.mckesson.com/Pharmaceutical-Distribution/Plasma-Biologics/ |
| McKesson Specialty Health (McKesson Specialty Care Distribution Corporation) | 800-482-6700 | N/A | www.mckesson.com/specialty/ |
| Morris & Dickson Specialty Distribution (MDSD) | 318-798-5295 | 318-798-5237 | www.mdspecialtydist.com |
| Morris & Dickson Pharmaceutical Distributor | 318-798-5295 | 318-798-5237 | www.morrisdickson.com/ |
| Oncology Supply (Cencora) | 800-633-7555 | 800-248-8205 | www.oncologysupply.com/ |
| Distributor | Telephone | Fax | Web Orders |
|---|---|---|---|
| Cardinal Health Puerto Rico | 787-625-4200 | N/A | cardinalhealth.pr/ |
| Cesar Castillo (Puerto Rico) | 787-999-1616 | 787-999-1618 | cesarcastillo.com/ |
| Pharmacy | Telephone | Fax | Web Orders |
|---|---|---|---|
| AcariaHealth | 800-511-5144 | 877-541-1503 | www.acariahealth.com |
| Accredo | 888-608-9010 | 877-329-4605 | www.accredo.com |
| Alivia Specialty Pharmacy (Puerto Rico) | 787-979-2023 | N/A | www.aliviahealth.com/specialty-pharmacy |
| Biologics | 800-850-4306 | 800-823-4506 | biologics.mckesson.com/ |
| BioPlus Specialty Pharmacy | 866-514-8082 | 800-269-5493 | www.bioplusrx.com |
| CenterWell Specialty Pharmacy (formerly Humana Specialty Pharmacy) | 800-486-2668 | N/A | www.centerwellpharmacy.com/ |
| CVS Specialty | 800-237-2767 | 800-323-2445 | www.cvsspecialty.com |
| Onco360 (OncoMed Specialty) | 877-662-6633 | 877-662-6355 | www.onco360.com |
| Optum Specialty Pharmacy | 855-427-4682 | 877-342-4596 | specialty.optumrx.com/ |
| Special Care Pharmacy (Puerto Rico Only) | 787-783-8579 | 787-783-2951 | specialcarepr.com |
| Walgreens Specialty Pharmacy | 888-782-8443 | N/A | www.walgreens.com/topic/pharmacy/specialty-pharmacy.jsp |
The Co-pay Program (“Program”) is valid ONLY for patients with commercial (private or non-governmental) insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medicine. The Program is not available to patients whose prescriptions are reimbursed under any federal, state, or government-funded insurance programs (included but not limited to Medicare, Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs Programs) or where prohibited by law or by the patient's health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state or government-funded healthcare programs, the patient will no longer be eligible for the Program. The Program is not valid for Genentech medicines that are eligible to be reimbursed in their entirety by private insurance plans or other programs.
Under the Program, the patient may be required to pay a co-pay. The final amount owed by a patient may be as little as $0 for the Genentech medicine (see Program specific details available on the Program Website). The total patient out-of-pocket cost is dependent on the patient’s health insurance plan. The Program assists with the cost of the Genentech medicine only. It does not assist with the cost of other medicines, procedures or office visit fees. After reaching the maximum annual Program benefit amount, the patient will be responsible for all remaining out-of-pocket expenses. The Program benefit amount cannot exceed the patient’s out-of-pocket expenses for the Genentech medicine. The maximum Program benefit will reset every January 1st. The Program is not health insurance or a benefit plan. The patient’s non-governmental insurance is the primary payer. The Program does not obligate the use of any specific medicine or provider. Patients receiving assistance from charitable free medicine programs (such as the Genentech Patient Foundation) or any other charitable organizations for the same expenses covered by the Program are not eligible. The Program benefit cannot be combined with any other rebate, free trial or other offer for the Genentech medicine. No party may seek reimbursement for all or any part of the benefit received through the Program.
The Program may be accepted by participating pharmacies, physicians' offices or hospitals. Once a patient is enrolled, the Program will honor claims with a date of service that precedes the Programs' enrollment by 180 days. Claims must be submitted within 365 days from the date of service unless otherwise indicated. Use of these Programs must be consistent with all relevant health insurance requirements. The patient is responsible for complying with the Terms & Conditions of their insurance plan. Participating patients, pharmacies, physicians' offices and hospitals are responsible for reporting the receipt of all the Programs' benefits as required by any insurer or by law. Program benefits may not be sold, purchased, traded or offered for sale.
The patient or their guardian must be 18 years of age or older to receive Program assistance. The Program is only valid in the United States and U.S. Territories, is void where prohibited by law and shall follow state restrictions in relation to AB-rated generic equivalents (e.g., MA, CA) where applicable. Eligible patients will be automatically re-enrolled in the Program on an annual basis each January 1st. Eligible patients will be removed from the Program after 3 years of inactivity (e.g., no claims submitted in a 3-year timeframe). Patients who choose reimbursement via virtual debit card will have access to the patient’s funds as long as the patient's virtual debit card is valid and the patient is active in the Program. Once a patient's virtual debit card has expired and they are no longer active in the program, the funds will be removed from the virtual debit card. Program eligibility and automatic re-enrollment are contingent upon the patient’s ability to meet all requirements set forth by the Program. Healthcare providers may not advertise or otherwise use the Program as a means of promoting their services or Genentech medicines to patients.
The value of the Program is intended exclusively for the benefit of the patient. The funds made available through the Program may only be used to reduce the out-of-pocket costs for the patient enrolled in the Program. The Program is not intended for the benefit of third parties, including without limitation third party payers, pharmacy benefit managers, or their agents. If Genentech determines that a third party has implemented a program that adjusts patient cost-sharing obligations based on the availability of support under the Program and/or excludes the assistance provided under the Program from counting towards the patient’s deductible or out-of-pocket cost limitations, Genentech may impose a per fill cap on the cost-sharing assistance available under the Program. Submission of true and accurate information is a requirement for eligibility and Genentech reserves the right to disqualify patients who do not comply with Genentech Program Terms and Conditions. Genentech reserves the right to rescind, revoke or amend the Program without notice at any time.
The Genentech Bridge Program (“Program”) provides eligible patients who have experienced an insurance coverage delay of 5 days minimum with up to a 30-day supply of Genentech Bridge medicine. If a coverage delay persists, a patient may be eligible for additional refills of the Genentech Bridge medicine. There is no obligation to purchase any future product and receipt of free product is not contingent on any past or future purchase. Requests for the Genentech Bridge medicine cannot be processed without a completed and signed 1)Product Prescriber Service Form and 2) Patient Consent Form. Patients must be prescribed the Genentech medicine for a valid FDA-approved indication. Neither the prescriber, the pharmacy, nor any patient receiving free Genentech medicine via the Genentech Bridge Program may seek reimbursement or credit for any part of the benefit received by the patient through this offer from any insurer, health plan, or government program.
The Genentech Bridge Program cannot be counted towards any out-of-pocket costs under any plan (such as true out-of-pocket cost under a Medicare Part D prescription drug plan). The Genentech Bridge Program enrollment team may notify the patient’s insurer that the patient is receiving a free supply of product from the Program. Prescribers may not advertise or otherwise use the Program as a means of promoting their services or Genentech’s medicines to patients. This Program is void where prohibited by law and may not be used in or by residents of restricted states, where applicable. The free supply may not be sold, purchased or traded or offered for sale. This Program is not a health insurance or benefit plan. Submission of true and accurate information is a requirement for eligibility and Genentech reserves the right to disqualify patients who do not comply with Genentech Program Terms and Conditions. Genentech reserves the right to rescind, revoke or amend the program without notice at any time.
This information contained in this site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.